Baidu
map
SCI IMMUNOL 润色咨询

Science Immunology

出版年份：暂无数据 年文章数：474 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2222035, encodeId=bc1322220351f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学<br>经验分享：8月20 submited<br>8月23 To advisor<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Fri Aug 23 12:17:50 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学<br>经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity<br>经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0<br>经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：covid-19<br>经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0<br>经验分享：投稿3个月了 邮件问说还在初步审稿没送审，速度很慢呀 有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊<span class="quote">Leopard FD 2019-02-15 00:00:00 发表:<br>Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。</span>, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=)]
    2024-08-23 朋友一场 来自北京

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向：免疫学
    经验分享：8月20 submited
    8月23 To advisor
    等待中。。。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2222035, encodeId=bc1322220351f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学<br>经验分享：8月20 submited<br>8月23 To advisor<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Fri Aug 23 12:17:50 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学<br>经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity<br>经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0<br>经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：covid-19<br>经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0<br>经验分享：投稿3个月了 邮件问说还在初步审稿没送审，速度很慢呀 有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊<span class="quote">Leopard FD 2019-02-15 00:00:00 发表:<br>Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。</span>, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=)]
    2023-04-07 ms7000001335611101 来自天津

    偏重的研究方向：免疫学
    经验分享：投稿分享 4-4投稿 4-5 Under Evaluation

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2222035, encodeId=bc1322220351f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学<br>经验分享：8月20 submited<br>8月23 To advisor<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Fri Aug 23 12:17:50 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学<br>经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity<br>经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0<br>经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：covid-19<br>经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0<br>经验分享：投稿3个月了 邮件问说还在初步审稿没送审，速度很慢呀 有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊<span class="quote">Leopard FD 2019-02-15 00:00:00 发表:<br>Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。</span>, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=)]
    2022-10-20 csw1314527

    偏重的研究方向：innate immunity
    经验分享：under evaluation 两周了，请问下大神这是什么情况

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2222035, encodeId=bc1322220351f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学<br>经验分享：8月20 submited<br>8月23 To advisor<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Fri Aug 23 12:17:50 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学<br>经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity<br>经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0<br>经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：covid-19<br>经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0<br>经验分享：投稿3个月了 邮件问说还在初步审稿没送审，速度很慢呀 有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊<span class="quote">Leopard FD 2019-02-15 00:00:00 发表:<br>Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。</span>, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=)]
    2022-02-26 MAC1234

    审稿速度:3.0
    经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2222035, encodeId=bc1322220351f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学<br>经验分享：8月20 submited<br>8月23 To advisor<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Fri Aug 23 12:17:50 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学<br>经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity<br>经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0<br>经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：covid-19<br>经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0<br>经验分享：投稿3个月了 邮件问说还在初步审稿没送审，速度很慢呀 有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊<span class="quote">Leopard FD 2019-02-15 00:00:00 发表:<br>Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。</span>, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=)]
    2022-09-06 guolihuihelan_91618321

    审稿速度:6.0 | 投稿命中率:5.0
    偏重的研究方向：covid-19
    经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2222035, encodeId=bc1322220351f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学<br>经验分享：8月20 submited<br>8月23 To advisor<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Fri Aug 23 12:17:50 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学<br>经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity<br>经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0<br>经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：covid-19<br>经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0<br>经验分享：投稿3个月了 邮件问说还在初步审稿没送审，速度很慢呀 有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊<span class="quote">Leopard FD 2019-02-15 00:00:00 发表:<br>Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。</span>, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=)]
    2022-02-18 ms1000001479366679

    审稿速度:6.0
    经验分享：投稿3个月了 邮件问说还在初步审稿没送审，速度很慢呀 有没有其他的朋友有类似的经历？

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2222035, encodeId=bc1322220351f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学<br>经验分享：8月20 submited<br>8月23 To advisor<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Fri Aug 23 12:17:50 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学<br>经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity<br>经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0<br>经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：covid-19<br>经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0<br>经验分享：投稿3个月了 邮件问说还在初步审稿没送审，速度很慢呀 有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊<span class="quote">Leopard FD 2019-02-15 00:00:00 发表:<br>Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。</span>, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=)]
    2020-10-11 charlene0316

    editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭

    10

    展开10条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2222035, encodeId=bc1322220351f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学<br>经验分享：8月20 submited<br>8月23 To advisor<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Fri Aug 23 12:17:50 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学<br>经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity<br>经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0<br>经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：covid-19<br>经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0<br>经验分享：投稿3个月了 邮件问说还在初步审稿没送审，速度很慢呀 有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊<span class="quote">Leopard FD 2019-02-15 00:00:00 发表:<br>Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。</span>, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=)]
    2021-01-13 丿柚子

    收不收综述？

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2222035, encodeId=bc1322220351f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学<br>经验分享：8月20 submited<br>8月23 To advisor<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Fri Aug 23 12:17:50 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学<br>经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity<br>经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0<br>经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：covid-19<br>经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0<br>经验分享：投稿3个月了 邮件问说还在初步审稿没送审，速度很慢呀 有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊<span class="quote">Leopard FD 2019-02-15 00:00:00 发表:<br>Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。</span>, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=)]
    2019-03-14 sunliang

    有好的稿子赶紧投，潜力股啊

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2222035, encodeId=bc1322220351f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：免疫学<br>经验分享：8月20 submited<br>8月23 To advisor<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Fri Aug 23 12:17:50 CST 2024, time=2024-08-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124248, encodeId=92c3212424872, content=偏重的研究方向：免疫学<br>经验分享：投稿分享 4-4投稿 4-5 Under Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Fri Apr 07 09:48:27 CST 2023, time=2023-04-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2094920, encodeId=ed5e20949206d, content=偏重的研究方向：innate immunity<br>经验分享：under evaluation 两周了，请问下大神这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94692322786, createdName=csw1314527, createdTime=Thu Oct 20 10:36:26 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197594, encodeId=b8a5119e594a0, content=审稿速度:3.0<br>经验分享：投稿science immunology两个多月了一直是under evaluation，发了N封邮件都不回，打电话也没人接，终于有一天有个editor回了我说正在等待评估，心中一万只草泥马奔腾而过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/84bf90008eb14883a640399b24452658/54a21c2bbe124b718a975508d9cb80bf.jpg, createdBy=0f5b5624592, createdName=MAC1234, createdTime=Sat Feb 26 21:34:41 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243407, encodeId=8e99124340eb6, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：covid-19<br>经验分享：这个月准备投，先来拜个山头，等接受了，再回来看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Sep 06 01:23:45 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194777, encodeId=71d81194e7779, content=审稿速度:6.0<br>经验分享：投稿3个月了 邮件问说还在初步审稿没送审，速度很慢呀 有没有其他的朋友有类似的经历？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6215509368, createdName=ms1000001479366679, createdTime=Fri Feb 18 12:02:50 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891178, encodeId=579a8911e810, content=editor assigned一个多月了还在under evaluation，有没有也是这样的，是不是editor太忙忘记了，发了两次邮件也没回😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a931717656, createdName=charlene0316, createdTime=Sun Oct 11 00:13:56 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916247, encodeId=9c0391624e5b, content=收不收综述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201020/ab7dee8018d2436d9c185605ca6df4d1/259e5aca63734597994109f6badb5036.jpg, createdBy=e5255379558, createdName=丿柚子, createdTime=Wed Jan 13 15:39:06 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568082, encodeId=16c756808238, content=有好的稿子赶紧投，潜力股啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Thu Mar 14 00:00:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567007, encodeId=aa6756e0071b, content=是啊，我也好想发一篇CNS子刊<span class="quote">Leopard FD 2019-02-15 00:00:00 发表:<br>Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。</span>, beContent=Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=606, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=)]
    2019-02-20 sunliang

    是啊，我也好想发一篇CNS子刊Leopard FD 2019-02-15 00:00:00 发表:
    Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。

    Leopard FD 2019-02-15 00:00:00 发表: Science 家族最新子刊，至此，CNS均有免疫领域的专业子刊了，由此可见这个领域是多么火热。

    0

共30条页码: 1/3页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map